While top-line numbers from Bloomberg suggest biotech M&A is down, other perspectives on Biotech M&A environment are more positive. Author shares a few different cuts of the data.
from Forbes Real Time //www.forbes.com/sites/brucebooth/2017/09/07/alternative-perspectives-on-the-biotech-ma-environment/
via IFTTT
No comments:
Post a Comment